Φορτώνει......
Autofluorescence imaging captures heterogeneous drug response differences between 2D and 3D breast cancer cultures
Two-photon microscopy of cellular autofluorescence intensity and lifetime (optical metabolic imaging, or OMI) is a promising tool for preclinical drug development. OMI, which exploits the endogenous fluorescence from the metabolic coenzymes NAD(P)H and FAD, is sensitive to changes in cell metabolism...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biomed Opt Express |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Optical Society of America
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5480588/ https://ncbi.nlm.nih.gov/pubmed/28663873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1364/BOE.8.001911 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|